M&A TRANSACTION · 2021
Global Nephrology Solutions acquired by Audax Private Equity
$375.0M· 12.5x EBITDA
Target
Global Nephrology Solutions
Acquirer
Audax Private Equity
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$30.0M
Deal Value
$375.0M
EV/EBITDA
12.5x
Context
This $375.0M acquisition of Global Nephrology Solutions by Audax Private Equity sits in the medical practice specialty sub-vertical. The 12.5x EBITDA multiple paid in 2021 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub. Audax Private Equity is acquiring as a private equity buyer; see how PE acquirers typically price medical practice specialty businesses on our Medical Practice Specialty PE buyer-pool page.
Source
Data sourced from Press releases and press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical practice specialty
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Global Nephrology Solutions acquisition.